Autologous Transplantation in Relapsed and Refractory Mantle Cell Lymphoma

被引：0
|
作者：
Shah, Bijal D.
Little, Bryan J. [1 ]
Cultrera, Jennifer [2 ]
Bello, Celeste M. [3 ]
Sokol, Lubomir
Sotomayor, Eduardo M.
Tomblyn, Marcie [4 ]
Ayala, Ernesto
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Heme FOB3, Tampa, FL 33682 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Hematopathol & Clin Med, Tampa, FL 33682 USA
[3] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Malignant Hematol, Tampa, FL 33682 USA
[4] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat, Tampa, FL 33612 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4542.4542
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4542
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Radioimmunotherapy (RIT) of relapsed or refractory mantle cell lymphoma (MCL)
    Elstrom, R
    Chong, E
    Andreadis, C
    Shrikanthan, S
    Downs, L
    Fellin, E
    Tsai, D
    Nasta, S
    Svoboda, J
    Maffi, J
    Alavi, A
    Schuster, S
    ANNALS OF ONCOLOGY, 2005, 16 : 170 - 170
  • [32] Relapsed/Refractory Mantle Cell Lymphoma: Beyond BTK Inhibitors
    Burkart, Madelyn
    Karmali, Reem
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (03):
  • [33] The shifting therapeutic paradigm for relapsed/refractory mantle cell lymphoma
    Kumar, Sumukh Arun
    Gao, Jenny
    Patel, Shyam A.
    LEUKEMIA RESEARCH, 2023, 134
  • [34] Evaluating pirtobrutinib for the treatment of relapsed or refractory mantle cell lymphoma
    Wang, Jacqueline F.
    Wang, Yucai
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (10) : 651 - 659
  • [35] Liso-Cel in Relapsed/Refractory Mantle Cell Lymphoma
    Wang, Michael
    ONCOLOGY-NEW YORK, 2024, 38 (07):
  • [36] Treatment Patterns and Outcomes in Relapsed/Refractory Mantle Cell Lymphoma
    Tawfiq, Reema K.
    Larson, Melissa C.
    Gile, Jennifer Jane
    Bock, Allison M.
    Poonsombudlert, Kittika
    Maliske, Seth M.
    Maurer, Matthew J.
    Cerhan, James R.
    Kabat, Brian
    Smith, Katherine
    Godby, Richard Curtis
    Paludo, Jonas
    Inwards, David J.
    Ayyappan, Sabarish
    Ansell, Stephen M.
    Habermann, Thomas M.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    Farooq, Umar
    Wang, Yucai
    BLOOD, 2022, 140 : 6489 - 6491
  • [37] Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus?
    Kirschey, Sebastian
    Wagner, Susanne
    Hess, Georg
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [38] Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma: A Single-Center Experience
    Matar, Charbel
    Ibrahim, Ali
    Alameddine, Raafat
    El Cheikh, Jean
    Bazarbachi, Ali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S310 - S311
  • [39] High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma
    Oyan, Basak
    Koc, Yener
    Ozdemir, Evren
    Kars, Ayse
    Turker, Alev
    Tekuzman, Gulten
    Kansu, Emin
    LEUKEMIA & LYMPHOMA, 2006, 47 (08) : 1545 - 1552
  • [40] Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
    Okay, M.
    Buyukasik, Y.
    Demiroglu, H.
    Malkan, U.
    Ciftciler, R.
    Aladag, E.
    Aksu, S.
    Haznedaroglu, I.
    Sayinalp, N.
    Ozcebe, O.
    Goker, H.
    LEUKEMIA RESEARCH, 2018, 73 : S27 - S27
12345